| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |